» Articles » PMID: 39271500

"Biomarkers in Severe Traumatic Brain Injury: Enhancing Prognostic Accuracy and Therapeutic Strategies"

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2024 Sep 13
PMID 39271500
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the emerging role of biomarkers in the prognosis and management of severe traumatic brain injury (sTBI). Key findings highlight the significance of serum RIP-3, STC1, Nrf2, and cerebrospinal fluid galectin-3 and cytokines in predicting disease severity, mortality, and functional outcomes in sTBI patients. Elevated levels of RIP-3 and STC1 were linked to poor prognosis and increased mortality, with RIP-3 associated with necroptosis and inflammation, and STC1 with neuroprotective properties. Nrf2 was found to correlate with oxidative stress and adverse outcomes, while elevated CSF galectin-3 and IL-6 indicated neuroinflammation and neurodegeneration. These biomarkers show promise not only as prognostic tools but also as potential therapeutic targets. The study suggests further validation through multicenter research to enhance clinical applications and improve treatment strategies for sTBI.

References
1.
Wang L, Zhang Y, Huang M, Yuan Y, Liu X . RIP3 in Necroptosis: Underlying Contributions to Traumatic Brain Injury. Neurochem Res. 2023; 49(2):245-257. DOI: 10.1007/s11064-023-04038-z. View

2.
Zou S, Xu J, Yang W, Chen Z, Shan H, Liu J . A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury. Neurosurg Rev. 2024; 47(1):433. DOI: 10.1007/s10143-024-02658-9. View

3.
Jin C, Huang X, Hu Y, Xu B, Ma J . A Prospective Longitudinal Cohort Study of Serum Stanniocalcin-1 as a Potential Prognostic Biomarker of Severe Traumatic Brain Injury. Ther Clin Risk Manag. 2024; 20:341-361. PMC: 11179674. DOI: 10.2147/TCRM.S463955. View

4.
Yan X, Zhan C, Lv Y, Mao D, Zhou R, Xv Y . Utility of serum nuclear factor erythroid 2-related factor 2 as a potential prognostic biomarker of severe traumatic brain injury in adults: A prospective cohort study. Front Neurol. 2022; 13:1013062. PMC: 9663921. DOI: 10.3389/fneur.2022.1013062. View

5.
Yip P, Leung W, Cetin M, Chang T, Yeap M, Chen C . Elevated cerebrospinal fluid galectin-3 and associated cytokines after severe traumatic brain injury in patients. Medicine (Baltimore). 2024; 103(31):e38620. PMC: 11296486. DOI: 10.1097/MD.0000000000038620. View